| MM | macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle... |
|---|---|
| SMCD | senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease |
| MD | Meningococcal Disease |
|---|---|
| MCD | Meningococcal disease |
| meningococcal infections | Infections with bacteria of the species neisseria meningitidis. (12 Dec 1998) |
|---|---|
| meningococcal meningitis | An acute infectious disease affecting children and young adults, caused by Neisseria meningitidis; characterised by nasopharyngeal catarrh, headache, vomiting, convulsions, stiffness in the neck (nuchal rigidity), photophobia, constipation, cutaneous hyperesthesia, a purpuric or herpetic eruption, and the presence of Kernig's sign. Fulminant form may cause Waterhouse-Friderichsen syndrome. Synonym: cerebrospinal fever, epidemic cerebrospinal meningitis. (05 Mar 2000) |
| acute fulminating meningococcal septicaemia | <radiology> Septicaemia (e.g., meningococcaemia), haemorrhagic necrosis of adrenals due to, septic emboli, disseminated intravascular coagulopathy (DIC), most likely to be adrenal haemorrhage and/or calcification (12 Dec 1998) |
|---|---|
| meningitis, meningococcal | Inflammation in response to infection with neisseria meningitidis of the pia-arachnoid and the fluid residing in the space which it encloses as well as the fluid in the ventricles of the brain. This condition occurs most often in children and adolescents. (12 Dec 1998) |
Synonyms : Infections, Meningococcal, Infection, Meningococcal, Meningococcal Infection
Synonyms : Bivalent Meningococcal Vaccine, Meningococcal Polysaccharide Vaccine, Meningococcal Vaccine, Menomune, Tetravalent Meningococcal Vaccine, Meningococcal Vaccine, Bivalent, Meningococcal Vaccine, Tetravalent, Polysaccharide Vaccine, Meningococcal
| meningococcal meningitis |
bacterial meningitis caused by infection with Neisseria meningitidis, an acute infectious disease with seropurulent meningeal inflammation. It usually appears in epidemics, and symptoms are those of acute cerebral and spinal meningitis, usually with an eruption of cutaneous erythematous, herpetic, or hemorrhagic spots. The fulminating or malignant form is known as Waterhouse-Friderichsen syndrome. Called also cerebrospinal fever and epidemic cerebrospinal m.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| meningococcal m. |
bacterial meningitis caused by infection with Neisseria meningitidis, an acute infectious disease with seropurulent meningeal inflammation. It usually appears in epidemics, and symptoms are those of acute cerebral and spinal meningitis, usually with an eruption of cutaneous erythematous, herpetic, or hemorrhagic spots. The fulminating or malignant form is known as Waterhouse-Friderichsen syndrome. Called also cerebrospinal fever and epidemic cerebrospinal m.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| meningococcal p. |
a rare type of bacterial pneumonia caused by the meningococcus Neisseria meningitidis; many cases are subclinical, but some infections become overwhelming, with fever, pleural effusion, and even death. Called also Neisseria meningitidis p.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| meningococcal polysaccharide v. |
a preparation of the group-specific capsular polysaccharide antigen of Neisseria meningitidis, types A, C, Y, or W-135; monovalent group A [USP] or C [USP], bivalent group A and C [USP], and quadrivalent vaccines are available. The vaccine is administered to persons over 2 years of age at risk for meningococcal disease caused by these serotypes and to all military recruits, and is recommended for persons deficient in any of the late complement components, those with asplenia, those with laboratory or industrial exposure to the bacterium, and those traveling or residing in areas hyperendemic for the disease. Administered subcutaneously.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| meningococcal vaccine |
A vaccine prepared from bacterial polysaccharides from certain types of meningococci. Meningococcal polysaccharide vaccines A, C, Y, and W135 are available for preventing diseases caused by those serogroups. A vaccine for m
Ãâó:
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|